Clinical Trial Update: Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies

View source ↗

Summary

The document reports a completed clinical evaluation of the SEQureDx T21 test for detecting Down syndrome and fetal aneuploidy in high-risk pregnancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome
• Fetal Aneuploidy

Snippet

Sponsor: Sequenom, Inc. | Conditions: Down Syndrome, Fetal Aneuploidy | Status: COMPLETED